Tudor‐Eliade Ciuleanu

Institute of Oncology Prof. Dr. Ion Chiricuta ORCID: 0000-0003-0958-5597

2

h-index

2

Publications

6,688

Citations

Publications

2 shown

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

Frances A. Shepherd , José Rodrigues Pereira , Tudor‐Eliade Ciuleanu +16 more

Erlotinib can prolong survival in patients with non-small-cell lung cancer after first-line or second-line chemotherapy.

2005 New England Journal of Medicine 5425 citations

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Edward B. Garon , Tudor‐Eliade Ciuleanu , Óscar Arrieta +23 more

2014 The Lancet 1263 citations

Frequent Co-Authors

Frances A. Shepherd

University Health Network

José Rodrigues Pereira

Eng Huat Tan

National Cancer Centre Singapore

Vera Hirsh

McGill University

Sumitra Thongprasert

Chiang Mai University

Daniel de Castro

Researcher Info

h-index: 2
Publications: 2
Citations: 6,688
Institution: Institute of Oncology Prof. Dr. Ion Chiricuta

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-0958-5597

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.